El‐Sayed El‐Awady
Impact in
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
- Geriatrics and Gerontology top 10%
Papers in
-
- Angiogenesis and VEGF in Cancer 1
-
- Chemotherapy-induced organ toxicity mitigation 1
- Co-authors
- Yasser M. Moustafa (5 shared papers)Asmaa Radwan (1 shared paper)Dina M. Abo‐Elmatty (1 shared paper)Sawsan A. Zaitone (2 shared papers)Mona F. El-Azab (2 shared papers)James M. O’Donnell (3 shared papers)David R. Mottram (3 shared papers)S. H. Moss (3 shared papers)
- Journals
- European Journal of Pharmacology (3 papers)American Journal of Pharmaceutical Education (2 papers)Pharmaceuticals (1 paper)The FASEB Journal (1 paper)Pharmacy Education (1 paper)
- Partner nations
- EgyptUnited KingdomSaudi Arabia
In The Last Decade
El‐Sayed El‐Awady
10 papers receiving 443 citations
Peers
Comparison fields: 5 of 84
- Molecular Medicine 40
- Geriatrics and Gerontology 24
- Pathology and Forensic Medicine 108
- Cardiology and Cardiovascular Medicine 93
- Pharmacology 26
Countries citing papers authored by El‐Sayed El‐Awady
This map shows the geographic impact of El‐Sayed El‐Awady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by El‐Sayed El‐Awady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites El‐Sayed El‐Awady more than expected).
Fields of papers citing papers by El‐Sayed El‐Awady
This network shows the impact of papers produced by El‐Sayed El‐Awady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by El‐Sayed El‐Awady. The network helps show where El‐Sayed El‐Awady may publish in the future.
Co-authors
The 16 scholars most cited alongside El‐Sayed El‐Awady, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 217 | |
| 2 | 2010 | 68 | |
| 3 | 2013 | 63 | |
| 4 | 2011 | 57 | |
| 5 | 2006 | 21 | |
| 6 | Sildenafil citrate protects against gastric mucosal damage induced by indomethacin in rats. | 2013 | 16 |
| 7 | 2010 | 5 | |
| 8 | 2025 | 3 | |
| 9 | 2007 | 3 | |
| 10 | 2006 | 2 | |
| 11 | 2024 | 0 |
About El‐Sayed El‐Awady
El‐Sayed El‐Awady is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Geriatrics and Gerontology, Cardiology and Cardiovascular Medicine and Epidemiology, having authored 11 papers that have together received 455 indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Chemotherapy-induced organ toxicity mitigation (1 paper), Fatty Acid Research and Health (1 paper), Online and Blended Learning (1 paper), Biochemical effects in animals (1 paper), Biochemical Acid Research Studies (1 paper) and Chemotherapy-induced cardiotoxicity and mitigation (1 paper). The work is most often cited by research in Molecular Medicine (40 citations), Geriatrics and Gerontology (24 citations), Pathology and Forensic Medicine (108 citations), Cardiology and Cardiovascular Medicine (93 citations) and Pharmacology (26 citations). El‐Sayed El‐Awady has collaborated with scholars based in Egypt, United Kingdom and Saudi Arabia. Frequent co-authors include Yasser M. Moustafa, Asmaa Radwan, Dina M. Abo‐Elmatty, Sawsan A. Zaitone, Mona F. El-Azab, James M. O’Donnell, David R. Mottram, S. H. Moss, Camilla I. Svensson and Simone Codeluppi. Their work appears in journals such as European Journal of Pharmacology, American Journal of Pharmaceutical Education, Pharmaceuticals, The FASEB Journal and Pharmacy Education.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.